Bal Pharma share price
You have to be logged in to add this to Watchlist.- ₹78.49(0.50%)April 20, 2026 15:27:12 PM IST
- NSE
- BSE
- Vol : 5.66 K (NSE + BSE)Last 20 day avg : 15.93 K
Bal Pharma is trading 0.50% upper at Rs 78.49 as compared to its last closing price. Bal Pharma has been trading in the price range of 80.36 & 77.30. Bal Pharma has given 6.68% in this year & 1.98% in the last 5 days. Bal Pharma has TTM P/E ratio 14.69 as compared to the sector P/E of 25.29.The company posted a net profit of 1.78 Crores in its last quarter.Listed peers of Bal Pharma include Sun Pharmaceutical Industries (-0.43%), Divi's Laboratories (0.62%), Torrent Pharmaceuticals (0.15%).The Mutual Fund holding in Bal Pharma was at -% in . The MF holding has - from the last quarter. The FII holding in Bal Pharma was at 0.14% in 31 Mar 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Apr 20, 2026, 04:50 PM UTC
- BetaMedium volatility1.08Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry1.94The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry1.53Annual dividends as a percentage of the stock price.
- P/BLower than historical values1.61The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values15.67Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation2.21The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bearish | 1,668.00 | -0.43 | 4,00,199.64 | 36.58 | 5.83 | 0.94 | 0.50 |
| Divi's Laboratories | Neutral | 6,267.60 | 0.62 | 1,66,341.02 | 72.91 | 10.69 | 0.50 | 0.01 |
| Torrent Pharmaceuticals | Bullish | 4,185.00 | 0.15 | 1,41,292.23 | 74.74 | 18.98 | 0.82 | 17.62 |
| Lupin | Bullish | 2,326.80 | 0.11 | 1,06,507.03 | 31.85 | 6.19 | 0.51 | 11.80 |
| Dr Reddy's Laboratories | Moderately Bearish | 1,229.50 | -0.48 | 1,02,318.12 | 18.54 | 3.12 | 0.64 | 2.34 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-11 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-11 | Quarterly Results, ESOP & A.G.M. |
| 2025-05-29 | Audited Results & Dividend |
| 2025-02-13 | Quarterly Results & Fund Raising |
- IndustryBiotechnology & Drugs
- ISININE083D01012
- BSE Code524824
- NSE CodeBALPHARMA
Bal Pharma is trading at 78.49 as on Mon Apr 20 2026 09:57:12. This is 0.50% upper as compared to its previous closing price of 78.10.
The market capitalization of Bal Pharma is 126.25 Cr as on Mon Apr 20 2026 09:57:12.
The 52 wk high for Bal Pharma is 119.60 whereas the 52 wk low is 59.69
Bal Pharma can be analyzed on the following key metrics -
- TTM P/E: 14.69
- Sector P/E: 25.29
- Dividend Yield: 1.53%
- D/E ratio: -
Bal Pharma reported a net profit of 7.22 Cr in 2025.
EQUITY QUICK LINKS
Bal Pharma QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.